Kai Kammers     |    kai.kammers@jhu.edu
DNA

Visit my Google Scholar profile.


Peer-reviewed Publications

  1. Ratovitski T, Chaerkady R, Kammers K, Stewart JC, Zavala A, Pletnikova O, Troncoso JC, Rudnicki DD, Margolis RL, Cole RN, Ross CA.
    Quantitative Proteomic Analysis Reveals Similarities between Huntington's Disease (HD) and Huntington's Disease-Like 2 (HDL2) Human Brains.
    J Proteome Res. 2016. [Advance online publication]
    PubMed | DOI
  2. Foster DB, Liu T, Kammers K, O'Meally R, Yang N, Papanicolaou KN, Talbot CC Jr, Cole RN, O'Rourke B.
    Integrated Omic Analysis of a Guinea Pig Model of Heart Failure and Sudden Cardiac Death.
    J Proteome Res. 2016. [Advance online publication]
    PubMed | DOI
  3. Matuschek C, Budach W, Bölke E, Geigis C, Kammers K, Ganswindt U, Scheckenbach K, Gripp S, Simiantonakis J, Hoffmann TK, Greve J, Gerber PA, Orth K, Roeder H, Hautmann MG, Budach W.
    Influence of dosimetric and clinical criteria on the requirement of artificial nutrition during radiotherapy of head and neck cancer patients.
    Radiother Oncol. 2016. [Advance online publication]
    PubMed | DOI
  4. Budach W, Bölke E, Kammers K, Gerber PA, Nestle-Krämling C, Matuschek C.
    Adjuvant radiation therapy of regional lymph nodes in breast cancer - a meta-analysis of randomized trials- an update.
    Radiat Oncol. 2015;10:258.
    PubMed | DOI
  5. Budach W, Bölke E, Kammers K, Gerber PA, Orth K, Gripp S, Matuschek C.
    Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials.
    Radiother Oncol. 2016;118(2):238-243.
    PubMed | DOI
  6. Wilky BA, Kim C, McCarty G, Montgomery EA, Kammers K, Cole RN, Raman V, Loeb D.
    RNA Helicase DDX3 - A novel therapeutic target in Ewing sarcoma.
    Oncogene. 2016;35(20):2574-2583.
    PubMed | DOI
  7. te Riele AS, James CA, Groeneweg JA, Sawant AC, Kammers K, Murray B, Tichnell C, van der Heijden JF, Judge DP, Dooijes D, van Tintelen JP, Hauer RN, Calkins H, Tandri H.
    Approach to family screening in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Eur Heart J. 2016;37(9):755-763.
    PubMed | DOI
  8. Matuschek C, Ochtrop T, Bölke E, Fenk R, Gripp S, Kröpil P, Gerber PA, Kammers K, Hamilton J, Orth K, Ganswindt U, Budach W.
    Effects of Radiotherapy in the treatment of multiple myeloma: a retrospective analysis of a single institution
    Radiat Oncol. 2015;10:71.
    PubMed | DOI
  9. Kammers K, Cole RN, Tiengwe C, Ruczinski I.
    Detecting significant changes in protein abundance.
    EuPA Open Proteom. 2015;7:11-19.
    PubMed | DOI | Software
  10. Linsler S, Kraemer D, Driess C, Oertel J, Kammers K, Rahnenführer J, Ketter R, Urbschat S.
    Molecular biological determinations of meningioma progression and recurrence.
    PLoS One. 2014;9(4):e94987.
    PubMed | DOI
  11. Hetzer S, Buhren BA, Schrumpf H, Bölke E, Meller S, Kammers K, Gerber PA, Homey B.
    Retrospective analysis of the frequency of centrofacial telangiectasia in systemic sclerosis patients treated with bosentan or ilomedin.
    Eur J of Med Res. 2014;19:2.
    PubMed | DOI
  12. Budach W, Kammers K, Bölke E, Matuschek C.
    Adjuvant radiotherapy of regional lymph nodes in breast cancer - a meta-analysis of randomized trials.
    Radiat Oncol. 2013;8:267.
    PubMed | DOI
  13. Kammers K, Lang M, Hengstler JG, Schmidt M, Rahnenführer J.
    Survival models with preclustered gene groups as covariates.
    BMC Bioinformatics. 2011;12:478.
    PubMed | DOI
  14. Matuschek C, Rudoy M, Peiper M, Gerber PA, Hoff NP, Buhren BA, Flehmig B, Budach W, Knoefel WT, Bojar H, Prisack HB, Steinbach G, Shukla V, Schwarz A, Kammers K, Erhardt A, Scherer A, Bölke E, Schauer M.
    Do insulin-like growth factor associated proteins qualify as a tumor marker? Results of a prospective study in 163 cancer patients.
    Eur J Med Res. 2011;16(10):451-456.
    PubMed | DOI
  15. Wemmert S, Bettscheider M, Alt S, Ketter R, Kammers K, Feiden W, Steudel WI, Rahnenführer J, Urbschat S.
    p15 promoter methylation - a novel prognostic marker in glioblastoma patients.
    Int J Oncol. 2009;34(6):1743-1748.
    PubMed | DOI


Book Chapters, Technical Reports, and Preprints

  1. Collado-Torres L, Nellore A, Kammers K, Ellis SE, Taub MA, Hansen KD, Jaffe AE, Langmead B, Leek JT.
    recount: A large-scale resource of analysis-ready RNA-seq expression data.
    bioRxiv. 2016.
    DOI
  2. Kammers K, Foster DB, Ruczinski I.
    Analysis of proteomic data. In Agnetti G, Lindsey ML, Foster DB (eds).
    Manual of Cardiac Proteomics. Springer International Publishing, Cham, Switzerland, 2016.
    DOI
  3. Kammers K, Rahnenführer J.
    Improved interpretability of survival models with gene groups as covariates.
    Technical Report, Department of Statistics, TU Dortmund University of Technology, 2010.